The MHRA Papers - Part 7

There’s a lack of crucial data, but not to worry - the clock is ticking.

SUMMARY: We are not sure about the potency of the stuff, RNA doing its own thing, the risk of anaphylaxis, Astra Zeneca’s use of polysorbate or their lack of data on severe cases or the elderly, but apart from that everything is OK and secret, of course.

We continue our review of the minutes of the meeting of the MHRA’s ​​Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group, which took place on 17 December 2020.

This very well-attended meeting (lots of secret members on the secret list or secret squirrels) discussed all three vaccines in contention for the prize of first to get the conditional market authorisation.

The Pfizer BioNTech vaccine batches did not appear very stable, with the mmRNA going off to do its own stuff in the vial…